<doc>
  <docmeta id="113hr2985ih">
    <bill congress="113" type="hr" number="2985" version="ih"/>
    <revision size="6059" annotations="0" status="complete" id="3" commit-time="2013-08-26T19:41:44Z" committer="mbohmer" doc="113hr2985ih/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H509D1D5477BD416E8A4E2A79E5D023A0" public-private="public">
	<metadata>
<dublinCore>
<title>113 HR 2985 IH: Combination Drug Development Incentive Act of 2013</title>
<publisher>U.S. House of Representatives</publisher>
<date>2013-08-02</date>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 2985</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130802">August 2, 2013</action-date>
			<action-desc>
        <sponsor name-id="C001076">Mr. Chaffetz</sponsor> (for
			 himself, <cosponsor name-id="C000556">Mr. Coble</cosponsor>, and
			 <cosponsor name-id="S000018">Mr. Salmon</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend section 505 of the Federal Food, Drug, and
		  Cosmetic Act to provide incentives for the development of new combination
		  drugs.</official-title>
	</form>
	<legis-body id="HD9F3F953D81540D68A0ED44FBD69B9C9" style="OLC">
		<section id="H5B00D10A136C41769C75F0F39B917617" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Combination Drug Development Incentive
			 Act of 2013</short-title>
        </quote> .</text>
		</section>
    <section id="H292583663A714EDBB1687662F4DDC3D6">
      <enum>2.</enum>
      <header>Applicability to
			 combination drugs submitted under a new drug application</header>
			<subsection id="HAA0045009ADA4DFE96A44732C27E52A1">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii">Clause (ii) of section 505(c)(3)(E) of the Federal Food,
			 Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355">
              <cato:entity-ref entity-type="uscode" value="usc/21/355/c/3/E/ii">21 U.S.C. 355(c)(3)(E)(ii)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph id="H9F1B903F8C8543BB9BEFF61F91C0C093">
          <enum>(1)</enum>
          <text>by striking
			 <quote>(ii) If an application submitted under subsection (b) for a drug, no
			 active ingredient (including any ester or salt of the active ingredient) of
			 which has been approved in any other application under subsection (b),</quote>
			 and inserting <quote>(ii)(I) If an application submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection (b)</cato:entity-ref>
			 for a drug, and described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:II" proposed="true">subclause (II)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:III" proposed="true">(III)</cato:entity-ref>,</quote>; and</text>
				</paragraph>
        <paragraph id="H654934D51AAC4763845715E710F6E775">
          <enum>(2)</enum>
          <text>by adding at the
			 end the following:</text>
					<quoted-block display-inline="no-display-inline" id="H9D35A29EF3D24BD18EF4B92CABEDF6AB" style="OLC">
						<subclause id="H196DC27C5BBE4AAEA29B5DA0B248340F" indent="up3">
              <enum>(II)</enum>
              <text display-inline="yes-display-inline">An application is described in this
				subclause if no active ingredient (including any ester or salt of the active
				ingredient) of the drug for which the application has been submitted has been
				approved in any other application under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection (b)</cato:entity-ref>.</text>
						</subclause>
            <subclause id="HD2244797CA1647E2820AA42652BAF010" indent="up3">
              <enum>(III)</enum>
              <text display-inline="yes-display-inline">An application is described in this
				subclause if—</text>
							<item id="H895672BE99F14C348EC2CCD466C7826E">
                <enum>(aa)</enum>
                <text>the application contains reports
				of new clinical investigations (other than bioavailability studies) essential
				to the approval of the application and conducted or sponsored by the
				applicant;</text>
							</item>
              <item id="HDD88328782884AB299FC3BF9892C2D6D">
                <enum>(bb)</enum>
                <text>the application is for a drug
				which contains a combination of active ingredients; and</text>
							</item>
              <item id="H0CDAB82021F948F2A582732FAB7AB147">
                <enum>(cc)</enum>
                <text>no such combination of active
				ingredients has been approved in any other application under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection
				(b)</cato:entity-ref>.</text>
							</item>
            </subclause>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection id="HC285AD9D404F4B1299587D89914D6C08">
        <enum>(b)</enum>
        <header>Applicability</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:I">Subclause
			 (I) of section 505(c)(3)(E)(ii) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as
			 designated by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Combination Drug Development Incentive Act of 2013/s:2/ss:a/p:1" proposed="true">subsection (a)(1)</cato:entity-ref>, is amended by striking <quote>is approved
			 after the date of the enactment of this clause</quote> and inserting <quote>is
			 approved after January 1, 2014, in the case of an application described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:II">subclause (II)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:III">subclause (III)</cato:entity-ref>
          </quote>.</text>
			</subsection>
      <subsection id="H92D26C88B56A4698882C909B7F97F752">
        <enum>(c)</enum>
        <header>Conforming
			 amendment</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:iii">Clause (iii) of section 505(c)(3)(E) of the Federal
			 Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355">
              <cato:entity-ref entity-type="uscode" value="usc/21/355/c/3/E">21 U.S.C. 355(c)(3)(E)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by striking
			 <quote>If</quote> and inserting <quote>Except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii">clause (ii)</cato:entity-ref>,
			 if</quote>.</text>
			</subsection>
    </section>
    <section id="H7AA86C57C8A14A50B46101D47FE8D2C1">
      <enum>3.</enum>
      <header>Applicability to
			 combination drugs submitted under an abbreviated new drug application</header>
			<subsection id="HF77508356AF043FE9A1B973F9BDF9554">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii">Clause (ii)</cato:entity-ref> of <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F">section 505(j)(5)(F) of the Federal Food,
			 Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355">
              <cato:entity-ref entity-type="uscode" value="usc/21/355/j/5/F">21 U.S.C. 355(j)(5)(F)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph id="HD6B7FEF1CF9A48009511170963A25741">
          <enum>(1)</enum>
          <text>by striking
			 <quote>(ii) If an application submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection (b)</cato:entity-ref> for a drug, no
			 active ingredient (including any ester or salt of the active ingredient) of
			 which has been approved in any other application under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection (b)</cato:entity-ref>,</quote>
			 and inserting <quote>(ii)(I) If an application submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection (b)</cato:entity-ref>
			 for a drug, and described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii/scl:II" proposed="true">subclause (II)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii/scl:III" proposed="true">(III)</cato:entity-ref>,</quote>; and</text>
				</paragraph>
        <paragraph id="H4FA49DB8BFEC45C781227D6E2E0783B0">
          <enum>(2)</enum>
          <text>by adding at the
			 end the following:</text>
					<quoted-block display-inline="no-display-inline" id="HEE12537B56EF4F6B8DC3DC3097B7323C" style="OLC">
						<subclause id="HDB17DFE8BC3F4B2B9E99476EF64B687F" indent="up4">
              <enum>(II)</enum>
              <text display-inline="yes-display-inline">An application is described in this
				subclause if no active ingredient (including any ester or salt of the active
				ingredient) of the drug for which the application has been submitted has been
				approved in any other application under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection (b)</cato:entity-ref>.</text>
						</subclause>
            <subclause id="HFC09C4C3234A46EEA8FCE64C2419EC14" indent="up4">
              <enum>(III)</enum>
              <text display-inline="yes-display-inline">An application is described in this
				subclause if—</text>
							<item id="H697A95823E3B4269AA30F5C3D814C4DC">
                <enum>(aa)</enum>
                <text>the application contains reports of
				new clinical investigations (other than bioavailability studies) essential to
				the approval of the application and conducted or sponsored by the
				applicant;</text>
							</item>
              <item id="H45EAAF17113142238CE00DF7E336201E">
                <enum>(bb)</enum>
                <text>the application is for a drug which
				contains a combination of active ingredients; and</text>
							</item>
              <item id="H364346FAB83D4DEFBFC98A105C490801">
                <enum>(cc)</enum>
                <text>no such combination of active
				ingredients has been approved in any other application under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:b">subsection
				(b)</cato:entity-ref>.</text>
							</item>
            </subclause>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection id="H400A3A0A471C49ABA3BC25B5CD00FC77">
        <enum>(b)</enum>
        <header>Applicability</header>
        <text display-inline="yes-display-inline">
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii/scl:I">Subclause (I) of section 505(j)(5)(F) of
			 the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as designated by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Combination Drug Development Incentive Act of 2013/s:3/ss:a/p:1" proposed="true">subsection (a)(1)</cato:entity-ref>,
			 is amended by striking <quote>is approved after the date of the enactment of
			 this subsection</quote> and inserting <quote>is approved after January 1, 2014,
			 in the case of an application described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/scl:II" proposed="true">subclause (II)</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/scl:III" proposed="true">subclause
			 (III)</cato:entity-ref>
          </quote>.</text>
			</subsection>
      <subsection id="HBFE929987CD54DCA994F66948E42A54A">
        <enum>(c)</enum>
        <header>Conforming
			 amendment</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:iii">Clause (iii)</cato:entity-ref> of <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F">section 505(j)(5)(F) of the Federal
			 Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355">
              <cato:entity-ref entity-type="uscode" value="usc/21/355/j/5/F">21 U.S.C. 355(j)(5)(F)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by striking
			 <quote>If</quote> and inserting <quote>Except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii">clause (ii)</cato:entity-ref>,
			 if</quote>.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>